Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Rosalind Advisors, Inc. > Profile

Instuitional Investor - Rosalind Advisors, Inc.

Fund Profile
Filing Period:
Fund Name: Rosalind Advisors, Inc.
Portfolio Value $121,420,416
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Lyra Therapeutics Inc.
 LYRA 1,888,720 $9,896,893 8.15%
2.
Myomo Inc.
 MYO 1,919,910 $9,618,749 7.92%
3.
Astria Therapeutics Inc
 1,128,708 $8,668,477 7.13%
4.
Xeris Biopharma Holdings Inc.
 XERS 3,543,685 $8,327,660 6.85%
5.
Viridian Therapeutics Inc.
 360,332 $7,848,031 6.46%
Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)